Abstract
Objective: The aim of this study was to investigate the hypothesis that interleukin-1β (IL-1β) might be involved in the increase of the circulating levels of placental-derived CRH leading to the initiation of pre-term labor. Subjects and methods: Forty-eight primigravidae with a singleton viable pregnancy between 28 and 34 weeks of gestation were studied. The subjects were divided in two groups: group A consisted of 30 pregnant women (mean age±SD; 22±1.1 yr old) presented with preterm labor (mean gestational age±SD; 30.6±2.3 weeks) and group B consisted of 18 pregnant women (24±2.6 yr old) with normal pregnancies (29.8±3.1 weeks). CRH and IL-1β levels were measured in blood specimens collected from all the study subjects on admission. Results: Women of group A presented significantly higher serum CRH levels (mean±SE; 1.18±1.83 ng/ml) compared to those of group B (0.48±0.67 ng/ml) (p<0.01). Similarly, serum IL-1β levels were significantly higher in women of group A (0.45±0.12 pg/ml) compared to those of group B (0.31±0.08 pg/ml) (p<0.01). A positive correlation was found between serum IL-1β and CRH (r=0.68, p=0.001) in women of group A (pre-term labor). Conclusions: Our findings suggest that the increased levels of IL-1β and CRH found in pregnant women presented with pre-term labor might be involved in the pathophysiologic mechanism of the latter. Furthermore, a positive interaction might exist between IL-1β and placental CRH which might lead to enhanced production of the second, facilitating, thus, the onset of labor.
Similar content being viewed by others
References
World Health Organisation: International of diseases and related healthy problems. 10th revision, Vol 2, Geneva: WHO. 1993.
Vogel I, Thorsen P, Curry A, Sandager P, Uldbjerg N. Biomarkers for the prediction of preterm delivery. Acta Obstet Gynecol Scand 2005, 84: 516–25.
Keelan JA, Coleman M, Mitchell MD. The molecular mechanisms of term and preterm labor: recent progress and clinical implications. Clin Obstet Gynecol 1997, 40: 460–78.
Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000, 21: 514–50
McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med 1995, 1: 460–3.
Schulte HM, Healy DL. Corticotropin releasing hormone-and adreno-corticotropin-like immunoreactivity in human placenta, peripheral and uterine vein plasma. Horm Metab Res 1987, 16(Suppl): 44–6.
Grino M, Chrousos GP, Margioris AN. The corticotropin releasing hormone gene is expressed in human placenta. Biochem Biophys Res Commun 1987, 148: 1208–14.
Petraglia F, Sawchenko PE, Rivier J, Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987, 328: 717–9.
Sehringer B, Zahradnik HP, Simon M, Ziegler R, Noethling C, Schaefer WR. mRNA expression profiles for corticotrophinreleasing hormone, urocortin, CRH-binding protein and CRH receptors in human term gestational tissues determined by real-time quantitative RT-PCR. J Mol Endocrinol 2004, 32: 339–48.
Smith R, Mesiano S, McGrath S. Hormone trajectories leading to human birth. Regul Pept 2002, 108: 159–64.
Wadhwa PD, Garite TJ, Porto M, et al. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am J Obstet Gynecol 2004, 191: 1063–9.
Wewers MD, Dare HA, Winnard AV, Parker JM, Miller DK. IL-1 beta-converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1 beta release limitation is ICE independent. J Immunol 1997, 159: 5964–72.
Opsjln SL, Wathen NC, Tingulstad S, et al. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993, 169: 397–404.
Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993, 77: 1690–4.
Mastorakos G, Magiakou MA, Chrousos GP. Effects of the immune/inflammatory reaction on the hypothalamic-pituitary-adrenal axis. Ann N Y Acad Sci 1995, 771: 438–48.
Petraglia F, Sutton S, Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotrophin-releasing factor from cultured human placental cells. Am J Obstet Gynecol 1989, 160: 247–51.
Petraglia F, Florio P, Nappi C, Genazzani AR. Peptide signalling in human placenta and membranes: autocrine, paracrine and endocrine mechanisms. Endocr Rev 1996, 17: 156–86.
Holzman C, Jetton J, Siler-Khodr T, Fisher R, Rip T. Second trimester corticotropin-releasing hormone levels in relation to preterm delivery and ethnicity. Obstet Gynecol 2001, 97: 657–63.
Majzoub JA, Karalis KP. Placental corticotropin-releasing hormone: function and regulation. Am J Obstet Gynecol 1999, 180: S242–6.
Riley SC, Walton JC, Herlick JM, Challis JR. The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab 1991, 72: 1001–7.
Erickson K, Thorsen P, Chrousos G, et al. Preterm birth: associated neuroendocrine, medical, and behavioral riskfactors. J Clin Endocrinol Metab 2001, 86: 2544–52.
Ruiz RJ, Fullerton J, Brown CE, Dudley DJ. Predicting risk of preterm birth: the roles of stress, clinical riskfactors, and corticotropin-releasing hormone. Biol Res Nurs 2002, 4: 54–64.
Smith R. The timing of birth. Sci Am 1999, 280: 68–75.
McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med 1995, 1: 460–3.
Grammatopoulos D, Hillhouse EW. Role of corticotropin-releasing hormone in onset of labour. Lancet 1999, 354: 1546–9.
Chan EC, Falconer J, Madsen G, et al. A corticotropin-releasing hormone type 1 receptor antagonist delays parturition in sheep. Endocrinology 1998, 139: 3357–60.
Grammatopoulos DK, Hillhouse EW. Activation of protein kinase C by oxytocin inhibits the biological activity of the human myometrial corticotropin-releasing hormone receptor at term. Endocrinology 1999, 140: 585–94.
Stevens MY, Challis JRG, Lye SJ. Corticotropin-releasing hormone receptor subtype 1 (CRH-R1) is significantly upregulated at the time of labor in the human myometrium. J Clin Endocrinol Metab 1998, 83: 1705–10.
Alvarez-de-la-Rosa M, Rebollo FJ, Codoceo R, Gonzalez Gonzalez A. Maternal serum interleukin 1, 2, 6, 8 and interleukin-2 receptor levels in preterm labor and delivery. Eur J Obstet Gynecol Reprod Biol 2000, 88: 57–60.
Perlstein RS, Whitnall MH, Abrams JS, Mougey EH, Neta R. Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993, 132: 946–52.
Mastorakos G, Bamberger C, Chrousos GP. Neuroendocrine regulation of the immune process. In: Plotnikoff NP ed. Cytokines-Stress and Immunity. In the series: Modern Endocrinology and Diabetes. CRC Press LLC, USA. 1999, 17–37.
Keelan JA, Sato T, Mitchell MD. Interleukin (IL)-6 and IL-8 production by human amnion: regulation by cytokines, growth factors, glucocorticoids, phorbol esters, and bacterial lipopolysaccharide. Biol Reprod 1997, 57: 1438–44.
Shim SS, Romero R, Hong JS, et al. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004, 191: 1339–45.
Bry K, Hallman M. Synergistic stimulation of amnion cell prostaglandin E2 synthesis by interleukin-1, tumor necrosis factor and products from activated human granulocytes. Prostaglandins Leukot Essent Fatty Acids 1991, 44: 241–5.
Steinborn A, Geisse M, Kaufmann M. Expression of cytokine receptors in the placenta in term and preterm labour. Placenta 1998, 19: 165–70.
Hagan P, Poole S, Bristow AF. Immunosuppressive activity of corticotrophin-releasing factor. Inhibition of interleukin-1 and interleukin-6 production by human mononuclear cells. Biochem J 1992, 281: 251–4.
Singh VK, Leu CSJ. Enhancing effect of corticotropinreleasing neurohormone on the production of interleukin-1 and interleukin-2. Neurosci Lett 1990, 120: 151–4.
Agelaki S, Tsatsanis C, Gravanis A, Margioris AN. Corticotropin-Releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun 2002, 70: 6068–74.
Zhao J and Karalis KP. Regulation of Nuclear Factor-κB by Corticotropin-Releasing hormone in mouse thymocytes. Mol Endocrinol 2002, 16: 2561–70.
Ghizzoni L, Mastorakos G, Vottero A, et al. Corticotropinreleasing hormone (CRH) inhibits steroid biosynthesis by cultured human granulosa-lutein cells in a CRH and Interleukin-1 receptor-mediated fashion. Endocrinology 1997, 138: 4806–11.
Rice GE, Freed KA, Aitken MA, Jacobs RA. Gestational-and labour-associated changes in the relative abundance of prostaglandin G/H synthase-1 and -2 mRNA in ovine placenta. J Mol Endocrinol 1995, 14: 237–45.
Mitchell MD, Romero R, Edwin SS, Trautman MS. Prostaglandins and parturition. Reprod Fertil Dev 1995, 7: 623–32.
Mitchell MD, Edwin SS, Lundin-Schiller S, Silver RM, Smotkin D, Trautman MS. Mechanism of interleukin -1β stimulation of human amnion prostaglandin biosynthesis: mediation via a novel inducible cyclooxygenase. Placenta 1993, 14: 615–25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vitoratos, N., Mastorakos, G., Kountouris, A. et al. Positive association of serum interleukin-1β and CRH levels in women with pre-term labor. J Endocrinol Invest 30, 35–40 (2007). https://doi.org/10.1007/BF03347393
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347393